(PDF) P1.12-03 a Prospective Study of Apatinib in Advanced

P1.12-03 a Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed From Two or More Lines of Chemotherapy

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.838

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

Feasibility Study of Personalized Peptide Vaccination for Advanced Non-Small Cell Lung Cancer Patients Who Failed Two or More Treatment Regimens

International Journal of Oncology

Cancer Research

English

P2.01-017 Study on the Effect of Apatinib Salvage Treatment of Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Treatment Results Including More Than Third-Line Chemotherapy for Patients With Advanced Non-Small Cell Lung Cancer

Oncology Letters

Cancer Research

English

P1.12-09 the Effect of Site of First Chemotherapy on Small Cell Lung Cancer Patient Outcomes

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-131 Apatinib as an Alternative for Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer

English

P1.12-14 Survival of Patients With Small-Cell Lung Cancer Undergoing Surgical Resection

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.12-02 Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients With Extensive Disease of Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

A Prospective, Randomized Study to Compare Two Palliative Radiotherapy Schedules in Advanced Non-Small Cell Lung Cancer (Stage IV)

Journal of Medical Science And clinical Research

English